LINC01111 and pachyonychia congenita: The tumor volume increased much more slowly, and the tumor weight was lower at the 6th week in the LINC01111-UP group compared with the NControl group (Fig. 2d, f), whereas the LINC01111-KD group showed the inverse results (Fig. 2e, g), indicating that LINC01111 overexpression remarkably inhibited the tumorigenic capability, while LINC01111 knockdown promoted the tumorigenic capability of PC cells in vivo.